Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthias Bodenstedt currently holds 1,188,510 shares of MoonLake Immunotherapeutics (MLTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthias Bodenstedt has been a net seller of MLTX stock. They have purchased $98.8K and sold $7.6M worth of shares.
Matthias Bodenstedt's most recent insider trade was on Apr 10, 2026, when they sold 1,925 shares at $19.51 per share.
Matthias Bodenstedt serves as Executive at MoonLake Immunotherapeutics (MLTX). They have executed 13 insider transactions totaling $7.7M over their tenure at the company.
Matthias Bodenstedt holds the position of Executive at MoonLake Immunotherapeutics, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Matthias Bodenstedt has shown a selling trading pattern, with $98.8K in total purchases and $7.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthias Bodenstedt was on Dec 19, 2023, when they sold $5.6M worth of MLTX shares. This transaction involved 94,736 shares at $59.22 per share.
Matthias Bodenstedt currently owns 1,188,510 shares of MoonLake Immunotherapeutics (MLTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthias Bodenstedt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthias Bodenstedt has 13 Form 4 filings on record as an insider at MoonLake Immunotherapeutics.
Set alerts for Matthias Bodenstedt and 40,000+ other insiders.